Skip to main navigation Skip to search Skip to main content

MicroRNA profiling in cancer

  • Reinhold Munker
  • , George A. Calin

Research output: Contribution to journalReview articlepeer-review

157 Scopus citations

Abstract

The diagnosis of cancer has undergone major changes in the last 40 years. Once based purely on morphology, diagnosis has come to incorporate immunological, cytogenetic and molecular methods. Many cancers, especially leukaemias, are now defined by molecular markers. Gene expression profiling based on mRNA has led to further refinement of the classification and diagnosis of cancer. More recently, miRNAs (microRNAs), among other small non-coding RNA molecules, have been discovered and found to be major players in cell biology. miRNAs, having both oncogenic and tumour-suppressive functions, are dysregulated in many types of cancer. miRNAs also interfere with metastasis, apoptosis and invasiveness of cancer cells. In the present review, we discuss recent advances in miRNA profiling in human cancer. We discuss both frequent and rare tumour types and give an outlook on future developments.

Original languageEnglish
Pages (from-to)141-158
Number of pages18
JournalClinical Science
Volume121
Issue number4
DOIs
StatePublished - Aug 2011

Funding

FundersFunder number
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer InstituteP01CA016672

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Cancer
    • Gene expression profile
    • Leukaemia
    • Malignancy
    • Microrna
    • Non-coding RNA

    ASJC Scopus subject areas

    • General Medicine

    Fingerprint

    Dive into the research topics of 'MicroRNA profiling in cancer'. Together they form a unique fingerprint.

    Cite this